Toxic Epidermal Necrolysis in a Patient with HLA-B*5901 Haplotype Caused by Topical and Oral Carbonic Anhydrase Inhibitors
Open Access
- 1 January 2014
- journal article
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 26 (5) , 645-646
Abstract
Cheon M, et al. Ann Dermatol. 2014 Oct;26(5):645-646. http://dx.doi.org/10.5021/ad.2014.26.5.645Keywords
This publication has 5 references indexed in Scilit:
- Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis2012
- HLA-B*5901 is Strongly Associated with Methazolamide-Induced Stevens–Johnson Syndrome/Toxic Epidermal NecrolysisPharmacogenomics, 2010
- The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma AgentsCurrent Pharmaceutical Design, 2008
- Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and DorzolamideAnnals of Dermatology, 2008
- Allelic and haplotypic diversity of HLA‐A, ‐B, ‐C, ‐DRB1, and ‐DQB1 genes in the Korean populationTissue Antigens, 2005